PD-1 blockade combined with chemotherapy and bevacizumab in DNA mismatch repair-proficient/microsatellite stable colorectal liver metastases
PD-1 blockade combined with chemotherapy and bevacizumab might be safe and effective for patients with pMMR/MSS CRLM. This treatment strategy might lead to better tumor regression and a higher chance of achieving NED.
Authors
- Yinghua Duan
- Jun Huang
- Guangjian Liu (ORCID: https://orcid.org/0000-0001-9275-9214)
- Yandong Zhao (ORCID: https://orcid.org/0000-0001-8661-0229)
- Qianqian Men
- Wan He (ORCID: https://orcid.org/0000-0003-1137-3833)
- Lishuo Shi (ORCID: https://orcid.org/0000-0002-0715-9941)
- Fengyun Pei
- Qijun Yao
Institutions
- Sun Yat-sen University (CN)
- Sixth Affiliated Hospital of Sun Yat-sen University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Journal of Gastrointestinal Oncology
- Published
- 2024-08-01
- DOI
- https://doi.org/10.21037/jgo-23-940
- Citations
- 2
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- National Natural Science Foundation of China
- Sun Yat-sen University